Highlights The first incretin hormone, gastric inhibitory peptide, was identified in the early 1970s, followed by the discovery of glucagonlike peptide 1 (GLP-1) in the 1980s [1]
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of prescription medications originally developed for type 2 diabetes that have been shown to produce significant weight loss
And then if you are high risk, of course, have another exam done shortly after starting just to make sure that youre not one of the people that fall into one of those categories where there can be worsening of the disease. I think its most important that these types of research projects continue to be done, and the benefit of having our electronic medical record systems, and we see in other countries that have kind of universal systems, you can do these very large population-based statistical analyses
We also offer package options for 3 and 6 months
"I understand the importance of lifestyle modification, and I am committed to continuing those efforts